trending Market Intelligence /marketintelligence/en/news-insights/trending/a5ogRjPg6nf2FxlRRgXN3Q2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Icade to appoint new board chairman

Gauging Supply Chain Risk In Volatile Times

The Commercial Real Estate (CRE) Sector Feels the Impact of the Coronavirus

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report


Icade to appoint new board chairman

Icade named Frédéric Thomas as its new board chairman, replacing André Martinez, who is not seeking reappointment to the board.

The French real estate investment trust said it will elect Thomas as chairman at its board meeting, to be held after its April 24 general meeting, noting that it will also appoint a vice chairman. Thomas is CEO of both Crédit Agricole Assurances SA and Predica.

Icade's board also plans to appoint three directors, including Emmanuel Chabas, Waël Rizk and Gonzague de Pirey.

Chabas is head of real estate investments for Crédit Agricole Assurances. Rizk, who is deputy CFO of the Caisse des Dépôts Group, will replace Céline Senmartin, director of Banque des Territoires for the Normandie region. Icade noted that de Pirey, who is chairman of the Lapeyre Group, will replace Martinez as an independent director.

Following the general meeting, Icade's board will expand to 15 members from 14, including five independent directors.